Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Clinical trial NCT02273375 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02273375
- Sponsor
- Canadian Cancer Trials Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-24
- Primary completion
- 2025-07-23
- Enrollment
- 1415
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.